• Not just Zuma's home

    Nkandla could be a great cultural heritage tourism site, argues Unathi Henama.

  • Retribution will come

    Those who now pay the price for opposing a corrupt system shall rise again, says Solly Moeng.

  • Ego - the enemy within

    Successful people are humble in their aspirations and resilient in failure, says Ian Mann.

All data is delayed
See More

Glaxo sells stake in SA's Aspen for R8.47bn

Sep 29 2016 10:49

GlaxoSmithKline has disposed of the final portion of its stake in Aspen Pharmacare, less than a month after selling the company a portfolio of anesthetic medicines.


Glaxo to sell rest of stake in SA’s Aspen

Sep 28 2016 19:43

GlaxoSmithKline will dispose of its remaining stake in Aspen Pharmacare less than a month after selling the SA company a portfolio of anaesthetic medicines.


Pfizer abandons plan to split into two companies

Sep 26 2016 16:23

US drug maker Pfizer, which has been considering a split into two companies for more than two years, has said it will not do so because the move would not create any shareholder value.


Ascendis' strength lies in diversification - CEO

Sep 16 2016 17:36

The strength of the business of Ascendis Health lies in its diversification from a customer point of view - and from a product point of view, it makes the business resilient.


Aspen targets further Chinese acquisitions

Sep 15 2016 17:02

Aspen Pharmacare is seeking further acquisitions and adding salespeople in China as it targets the world’s most populous country as a major growth market.


Oprah loses $117m as Weight Watchers shares drop

Sep 15 2016 06:52

A drop in the shares of Weight Watchers, which Oprah Winfrey has a 10% stake in, has shaved off about $117m of her wealth, as the company seeks a new CEO.


Ascendis posts 39% revenue rise

Sep 14 2016 15:16

Ascendis Health has increased revenue by 39% to R3.9bn in the year to end-June 2016, with normalised headline earnings rising by 37% to R336m.


Aspen continues spending spree with $372m purchase

Sep 12 2016 12:26

Aspen Pharmacare says it has agreed to buy a portfolio of anaesthetic medicines from GlaxoSmithKline for as much as $372m.


Aspen heads for biggest decline in 17 years

Sep 08 2016 11:19

Aspen Pharmacare is headed for its biggest drop in almost 17 years as the sale of portfolios and a currency-related loss in Venezuela are set to weigh on earnings.


MMI's full-year profit slumps 25%

Sep 07 2016 20:09

MMI Holdings says fiscal full-year profit dropped 25% after underwriting slumped and investment returns declined.

Inside Fin24.com


AstraZeneca injection helps with severe asthma in advanced test

Sep 05 2016 09:22

AstraZeneca has said its experimental injection benralizumab helped improve lung function and alleviate symptoms in patients with severe asthma in two advanced clinical trials.


Adcock appoints new executive director

Aug 28 2016 15:30

Basadifeela Letsoalo has been appointed as executive director for human capital and transformation, says Adcock Ingram.

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Do you use all your downloaded apps on your smartphone?

Previous results · Suggest a vote